Cargando…
Inhibition of NF-κB activation by BAY 11-7821 suppresses the proliferation and inflammation of glioma cells through inducing autophagy
BACKGROUND: Gliomas have been known as the most common intracranial malignant tumor, and this kind of tumors cause huge amounts of mortality. The NF-κB inhibitor BAY 11-7821 has been reported as a novel approach in the immunotherapy of lung diseases. However, the functional role of BAY 11-7821 and i...
Autores principales: | Xie, Kui, Zhou, Deming, Fang, Chao, Pu, Rong, Zhu, Zhanpeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8904953/ https://www.ncbi.nlm.nih.gov/pubmed/35281421 http://dx.doi.org/10.21037/tcr-21-2914 |
Ejemplares similares
-
Olanzapine induced autophagy through suppression of NF‐κB activation in human glioma cells
por: Zhu, Ying, et al.
Publicado: (2019) -
Effects of the NF-κB Signaling Pathway Inhibitor BAY11-7082 in the Replication of ASFV
por: Gao, Qi, et al.
Publicado: (2022) -
Synergistic inhibition of lung cancer cells by EGCG and NF-κB inhibitor BAY11-7082
por: Zhang, Lingyu, et al.
Publicado: (2019) -
U0126 and BAY11-7082 Inhibit the Progression of Endometriosis in a Rat Model by Suppressing the MEK/ERK/NF-κB Pathway
por: Wang, Fang, et al.
Publicado: (2023) -
Autophagy in HCV Infection: Keeping Fat and Inflammation at Bay
por: Vescovo, Tiziana, et al.
Publicado: (2014)